Find link

language:

Find link is a tool written by Edward Betts.

searching for Vitamin K antagonist 17 found (50 total)

CHA2DS2–VASc score (2,887 words) [view diff] exact match in snippet view article find links to article

score of 2 and above, oral anticoagulation therapy (OAC) with a vitamin K antagonist (VKA, e.g. warfarin with target INR of 2-3) or one of the direct

Prothrombin time (3,091 words) [view diff] exact match in snippet view article find links to article

the vitamin K antagonist at an adjusted lower dose when the target INR is reached. For people who need rapid reversal of the vitamin K antagonist – such

Calciphylaxis (2,942 words) [view diff] exact match in snippet view article find links to article

kidney disease patients are also on a medication called warfarin, a vitamin K antagonist, that limits vitamin K recycling in the body. Reported risk factors

Des-gamma carboxyprothrombin (561 words) [view diff] exact match in snippet view article find links to article

determination in the detection of intoxication with acenocoumarol, a vitamin K antagonist. Liebman HA, Furie BC, Tong MJ, et al. (1984). "Des-gamma-carboxy

Raffaele De Caterina (955 words) [view diff] case mismatch in snippet view article find links to article

2021;144:983–996. De Caterina R, Ageno W, Agnelli G, et al.: The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations

Johannes Hoffmann (vascular surgeon) (962 words) [view diff] exact match in snippet view article

complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding, Crit. Care 2009 13(6):

Fenofibrate (2,461 words) [view diff] exact match in snippet view article find links to article

anticoagulants to increase the risk of bleeding. Dosage adjustment of vitamin K antagonist may be necessary. Statins: Combination of statins and fenofibrate

Metachromatic leukodystrophy (3,183 words) [view diff] exact match in snippet view article find links to article

clinical trial underway to determine the safety and efficacy of a Vitamin K antagonist (Warfarin) in treating Metachromatic Leukodystrophy (MLD) in 2009

North Bristol NHS Trust (2,053 words) [view diff] exact match in snippet view article find links to article

list (link) A Rahman, Ishtiaq; Vohra, Hunaid (16 April 2018). "Non vitamin K antagonist oral anticoagulation- The future of anticoagulation following mitral

Verification and validation (4,954 words) [view diff] exact match in snippet view article find links to article

Augueste; et al. (2008). "Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective

P-glycoprotein (3,960 words) [view diff] case mismatch in snippet view article find links to article

Biomed Sci 2019:76;150-152 Health, Ministry of (2015). "Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation –

Vitamin K reaction (2,749 words) [view diff] case mismatch in snippet view article find links to article

of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters". Journal of Osteoporosis

Protein C (5,390 words) [view diff] exact match in snippet view article find links to article

protein C deficiency due to treatment with warfarin, which is a vitamin K antagonist and an anticoagulant itself. However, warfarin treatment may produce

Sulfatide (5,620 words) [view diff] exact match in snippet view article find links to article

biosynthesis of brain phospholipids, such as sulfatide. When warfarin, a vitamin K antagonist, is added to an animal model system, sulfatide synthesis is impaired

Osteoporosis (13,910 words) [view diff] case mismatch in snippet view article find links to article

of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters". Journal of Osteoporosis

Atrial fibrillation (17,194 words) [view diff] case mismatch in snippet view article find links to article

GY, et al. (March 2018). "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation

Discovery and development of direct Xa inhibitors (4,917 words) [view diff] case mismatch in snippet view article find links to article

(2016). "Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa". Clinical Pharmacokinetics